The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci
Open accessAbstract
Our previous studies have shown that recombinant multivalent vaccines containing amino-terminal M protein fragments from as many as 26 different serotypes of group A streptococci (GAS) evoked opsonic antibodies in animals and humans. In the present study, we constructed a new 30-valent vaccine containing M protein peptides from GAS serotypes prevalent in North America and Europe. The vaccine was immunogenic in rabbits and evoked bactericidal antibodies against all 30 vaccine serotypes of GAS. In addition, the vaccine antisera also contained significant levels of bactericidal antibodies against 24 of 40 non-vaccine serotypes of GAS. These results indicate that the potential efficacy of the new multivalent vaccine may be greater than predicted based on the "type-specific" M peptides represented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global burden of group A streptococcal diseases
Carapetis, J. R., Steer, A. C., Mulholland, E. K., & Weber, M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70267-x · Cited by 2,998
Steer, A. C., Law, I., Matatolu, L., Beall, B. W., & Carapetis, J. R. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70178-1 · Cited by 537
O'Loughlin, R. E., Roberson, A., Cieslak, P. R., Lynfield, R., Gershman, K., Craig, A., Albanese, B. A., Farley, M. M., Barrett, N. L., Spina, N. L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/521264 · Cited by 499
Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers
McNeil, S. A., Halperin, S. A., Langley, J. M., Smith, B., Warren, A., Sharratt, G. P., Baxendale, D. M., Reddish, M. A., Hu, M. C., Stroop, S. D., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/444458 · Cited by 305
Self-citationClinical and Microbiological Characteristics of Severe Streptococcus pyogenes Disease in Europe
Luca-Harari, B., Darenberg, J., Neal, S., Siljander, T., Strakova, L., Tanna, A., Creti, R., Ekelund, K., Koliou, M., Tassios, P. T., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02155-08 · Cited by 300
Immunogenicity of a 26-Valent Group A Streptococcal Vaccine
Hu, M. C., Walls, M. A., Stroop, S. D., Reddish, M. A., Beall, B., & Dale, J. B. (2002) · Infection and Immunity · doi:10.1128/iai.70.4.2171-2177.2002 · Cited by 241
Self-citationKotloff, K. L., Corretti, M., Palmer, K., Campbell, J. D., Reddish, M. A., Hu, M. C., Wasserman, S. S., & Dale, J. B. (2004) · JAMA · doi:10.1001/jama.292.6.709 · Cited by 173
Self-citationShulman, S. T., Stollerman, G. H., Beall, B., Dale, J. B., & Tanz, R. R. (2006) · Clinical Infectious Diseases · doi:10.1086/499812 · Cited by 128
Self-citationGroup A streptococcal vaccines: facts versus fantasy
Steer, A. C., Batzloff, M. R., Mulholland, K., & Carapetis, J. R. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328332bbfe · Cited by 121
Dale, J. B. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00150-9 · Cited by 115
Self-citationSeven‐Year Surveillance of North American Pediatric Group A Streptococcal Pharyngitis Isolates
Shulman, S. T., Tanz, R. R., Dale, J. B., Beall, B., Kabat, W. J., Kabat, K., Cederlund, E., Patel, D., Rippe, J., Li, Z., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/599344 · Cited by 111
Self-citationNew protective antigen of group A streptococci
Dale, J. B., Chiang, E. Y., Liu, S., Courtney, H. S., & Hasty, D. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5118 · Cited by 64
Self-citationCurrent Status of Group A Streptococcal Vaccine Development
Dale, J. B. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-73960-1_5 · Cited by 54
Self-citation
Cited by
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-13 · Cited by 908
Acute rheumatic fever and rheumatic heart disease
Carapetis, J. R., Beaton, A., Cunningham, M. W., Guilherme, L., Karthikeyan, G., Mayosi, B. M., Sable, C., Steer, A., Wilson, N., Wyber, R., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.84 · Cited by 706
Staphylococcal and Streptococcal Superantigen Exotoxins
Spaulding, A. R., Salgado-Pabón, W., Kohler, P. L., Horswill, A. R., Leung, D. Y. M., & Schlievert, P. M. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00104-12 · Cited by 540
The role of vaccines in combatting antimicrobial resistance
Micoli, F., Bagnoli, F., Rappuoli, R., & Serruto, D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00506-3 · Cited by 500
Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005–2012
Nelson, G. E., Pondo, T., Toews, K.-A., Farley, M. M., Lindegren, M. L., Lynfield, R., Aragon, D., Zansky, S. M., Watt, J. P., Cieslak, P. R., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw248 · Cited by 404
Metadata
- Authors
- Dale, J. B., Penfound, T. A., Chiang, E. Y., & Walton, W. J.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 29
- Issue
- 46
- Pages
- 8175-8178
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2084258602
- Cited by
- 258
- References
- 13
- FWCI
- 13.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.